Brief: Corline Biomedical Completes Directed Issue Of About SEK 35.5 Million
March 30 (Reuters) - Corline Biomedical AB CLBIO.ST>:
* SAID ON MONDAY HAD COMPLETED A DIRECTED ISSUE OF ABOUT SEK
35.5
MILLION
* COMPLETED A DIRECTED CASH ISSUE OF 3,300,000 ORDINARY
SHARES AT
A SUBSCRIPTION PRICE OF SEK 10.75 PER SHARE
* THE ISSUE WAS SUBSCRIBED FOR BY SWEDISH INSTITUTIONAL
INVESTORS,
INCLUDING M2 ASSET MANAGEMENT, AND THE EXISTING SHAREHOLDER
HEALTHINVEST PARTNERS
Source text for Eikon: urn:newsml:reuters.com:*:nGNEbt9HN
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln